CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
54.98
+13.05 (31.11%)
Jan 9, 2026, 1:54 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Backbone Bladder-sparing Therapeutic
1.14M
Log In
Log In
Log In
Backbone Bladder-sparing Therapeutic Growth
458.33%
Log In
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
1.14M
Log In
Log In
Log In
United States Growth
458.33%
Log In
Log In
Log In